Consistent with this, Singh et al. demonstrated that B cells producing pathogenic autoantibodies frequently harbor lymphoma-associated mutations, such as those affecting NF-κB signaling, further linking autoimmunity to lymphoma development3. Here, NFKB1 is linked to lymphoma.